Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-SAM: Antimicrobial and Psychosocial Interventions for Complicated Severe Acute Malnutrition
NCT05994742Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of azithromycin, isoniazid, rifampicin, pyridoxine in severe acute malnutrition (SAM), sponsored by Queen Mary University of London. Started Jul 2024; status: completed.
02
Drugs
azithromycinisoniazidrifampicinpyridoxine
03
Conditions
severe acute malnutrition (SAM)
Beyond the preview
Go deeper on NCT05994742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994742.